Louise A. Donnelly

Dundee, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications

One-year usage patterns of SGLT-2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes in a real-world population.

One-year usage patterns of SGLT-2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes in a real-world population.

Journal: Diabetes, obesity & metabolism
Published: September 10, 2025

The influence of metformin treatment on the circulating proteome.

The influence of metformin treatment on the circulating proteome.

Journal: EBioMedicine
Published: February 11, 2025

Trajectories of BMI before and after diagnosis of type 2 diabetes in a real-world population.

Trajectories of BMI before and after diagnosis of type 2 diabetes in a real-world population.

Journal: Diabetologia
Published: February 09, 2024

Multi-omics subgroups associated with glycaemic deterioration in type 2 diabetes: an IMI-RHAPSODY Study.

Multi-omics subgroups associated with glycaemic deterioration in type 2 diabetes: an IMI-RHAPSODY Study.

Journal: Frontiers in endocrinology
Published: December 06, 2023

Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes.

Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes.

Journal: Diabetologia
Published: November 29, 2023

Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes.

Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes.

Journal: Diabetologia
Published: October 17, 2023

An omics-based machine learning approach to predict diabetes progression: a RHAPSODY study.

An omics-based machine learning approach to predict diabetes progression: a RHAPSODY study.

Journal: Diabetologia
Published: July 03, 2023

Initiation of glucose-lowering drugs reduces the anticoagulant effect of warfarin-But not through altered drug metabolism in patients with type 2 diabetes.

Initiation of glucose-lowering drugs reduces the anticoagulant effect of warfarin-But not through altered drug metabolism in patients with type 2 diabetes.

Journal: British journal of clinical pharmacology
Published: January 12, 2023

Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study.

Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study.

Journal: Diabetes care
Published: June 23, 2022

The impact of birthweight on subsequent phenotype of type 2 diabetes in later life.

The impact of birthweight on subsequent phenotype of type 2 diabetes in later life.

Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: August 03, 2021

Identification of biomarkers for glycaemic deterioration in type 2 diabetes.

Identification of biomarkers for glycaemic deterioration in type 2 diabetes.

Journal: Nature communications
Published: April 19, 2021

Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study.

Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study.

Journal: Diabetologia
Published: December 22, 2020
Showing 1-12 of 53

Last Updated: 09/26/2026